Related Experiment Videos
Chromosome banding patterns in patients with chronic myelocytic leukemia
Insights
Cytogenetic analysis of 109 chronic myelocytic leukemia patients revealed the Philadelphia chromosome (Ph1) in most cases. Ph1-negative cells and additional chromosome aberrations were observed, particularly in the blastic phase.
Area of Science:
- Hematology
- Cytogenetics
- Oncology
Background:
- Chronic myelocytic leukemia (CML) is a myeloproliferative neoplasm characterized by the Philadelphia chromosome (Ph1).
- Understanding the cytogenetic landscape of CML is crucial for diagnosis and prognosis.
Purpose of the Study:
- To cytogenetically characterize a cohort of 109 patients with Ph1-positive chronic myelocytic leukemia.
- To investigate the presence of Ph1-negative cells and additional chromosomal aberrations in different phases of CML.
Main Methods:
- Banding cytogenetic methods were employed to analyze bone marrow samples.
- Patients were studied in both the chronic and blastic phases of the disease.
Main Results:
- The standard Ph1 translocation was identified in 107 out of 109 patients.
- Ph1-negative cells were detected in 7% of cases, and additional chromosomal aberrations were observed in 8% during the chronic phase.
- Karyotypic findings in the blastic phase included trisomy 8, iso(17q), and a second Ph1, consistent with previous reports.
Conclusions:
- The study confirms the high prevalence of the Ph1 chromosome in CML.
- The presence of Ph1-negative cells and secondary chromosomal abnormalities may have prognostic implications.
- Variations in cytogenetic findings highlight the importance of standardized methods for inter-laboratory comparisons.
Abstract:
One hundred and nine patients with Ph1-positive chronic myelocytic leukemia were cytogenetically studied with banding methods. Seventy-eight patients were studied in the chronic phase and 39 patients in the blastic phase. The standard translocation was present in 107 cases. Two patients showed complex translocations involving chromosomes No. 6, 9, 22, 11 and No. 9, 22, 11, respectively. Ph1-negative cells were detected in 8 cases (7%). Chromosome aberrations in addition to the Ph1 chromosome were observed in 6 cases (8%) during the chronic phase. The karyotypic findings during the blastic phase were similar to those reported in the past [trisomy 8, iso(17q), and a second Ph1]. The significance of Ph1-negative cells, the geographic heterogeneity of the chromosomal aberrations, the effect of chemotherapy on the appearance of new clones, and the importance of the materials and methods used for the comparison of cytogenetic patterns at different laboratories are discussed.